Prophylactic Efficacy of Relenza Against Influenza A and B

Clinical trial NCT01156701 · COMPLETED

Trial details

NCT number: NCT01156701
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Pulmonary Disease, Chronic Obstructive Bronchospasm Influenza, Human Asthma Respiratory Disease Exacerbation of COPD Bronchitis Otitis Maedia Pneumonia Sinusitis

Start date: 2009-07-01
Primary completion: 2010-05-01
Enrollment: 171705

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.